Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Ubunifu wa Solomon wa Vikundi Vinne Unaojirekebisha× | Muundo wa Kikundi cha Solomon Nne× | |
|---|---|---|
| Nyanja | Muundo wa Majaribio | Muundo wa Majaribio |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1949 (base design); adaptive adaptation developed through later adaptive trial methodology | 1949 |
| Mwanzilishi≠ | Richard L. Solomon (base design); adaptive extension via response-adaptive randomization methodology | Richard L. Solomon |
| Aina≠ | Experimental design (pretest-sensitization control + adaptive randomization) | True experimental design |
| Chanzo asilia | Solomon, R. L. (1949). An extension of control group design. Psychological Bulletin, 46(2), 137–150. DOI ↗ | Solomon, R. L. (1949). An extension of control group design. Psychological Bulletin, 46(2), 137–150. DOI ↗ |
| Majina mbadala | adaptive S4G design, response-adaptive Solomon design, sequential Solomon four-group design, adaptive pretest-sensitization design | Solomon design, four-group design, Solomon four-group control design, S4GD |
| Zinazohusiana≠ | 6 | 5 |
| Muhtasari≠ | The Adaptive Solomon Four-Group Design combines the pretest-sensitization control of Solomon's classic four-group structure with response-adaptive randomization, allowing interim outcome data to update the allocation probabilities across the four groups as the study progresses. This hybrid preserves the design's ability to isolate the testing effect while improving ethical efficiency by steering more participants toward conditions performing better at interim checkpoints. | The Solomon Four-Group Design extends the classic pretest-posttest control-group design by adding two groups that receive no pretest, enabling researchers to detect whether the pretest itself alters participants' responses to the treatment. Introduced by Richard L. Solomon in 1949, it remains the gold standard for isolating the independent effect of a pretest and for obtaining unbiased estimates of treatment efficacy. |
| ScholarGateSeti ya data ↗ |
|
|